Cellular and Functional Characterization of Immunoresistant Human Glioma Cell Clones Selected With Alloreactive Cytotoxic T Lymphocytes Reveals Their Up-regulated Synthesis of Biologically Active TGF-β
Authors:
- 1 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 30 (3) , 261-273
Abstract
Two immunoresistant (IR) glioma cell variants, 13-06-IR29 and 13-06-IR30, were cloned from 13-06-MG glioma cell populations after receiving continuous immunoselective pressure from multiple alloreactive cytotoxic T lymphocyte (aCTL) preparations. Reapplication of aCTL immunoselective pressure to the IR clones, displaying a partial regain in sensitivity to aCTL after removal of the selective pressure, restored the resistance. The IR variants exhibited cross-resistance to non-human leukocyte antigen (HLA)-restricted effector cells and γ-irradiation, but not to carmustine. The IR clones were characterized for factors that might contribute to the immunoresistance. The aCTL adhesion to extracellular matrix extracts derived from either the IR clones or the parental cells was similar and not impaired. Furthermore, aCTL binding to parental cells and IR clones was equal. Down-regulation of the cell recognition molecules, class I HLA or intercellular adhesion molecule-1 (ICAM-1), that would inhibit their recognition by aCTL was not observerd on the IR clones. The down-regulation of Fas by the IR clones correlated with their resistance to FasL-induced apoptosis. HLA-G or FasL that might provide an immunotolerant environment or provide a means of counterattack to aCTL, respectively, were not associated with the IR phenotype. The aCTL, coincubated with the IR clones and parental cells, displayed up-regulation of multiple secreted cytokines. A significant up-regulation of bioactive transforming growth factor (TGF)-β was observed in the IR clones compared with the parental cells. These data suggest that increased secretion of bioactive TGF-β may inhibit aCTL lysis of the IR clones. Disruption of the TGF-β signaling pathway may circumvent the resistance.Keywords
This publication has 79 references indexed in Scilit:
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cellsClinical Immunology, 2004
- Exosomes bearing HLA-G are released by melanoma cellsHuman Immunology, 2003
- Tumor-Specific Cytotoxic T Lymphocyte Responses against Chondrosarcoma with HLA Haplotype Loss Restricted by the Remaining HLA Class I AlleleBiochemical and Biophysical Research Communications, 2001
- In Vitroandin VivoPotentiation of Radiosensitivity of Malignant Gliomas by Antisense Inhibition of the RAD51 GeneBiochemical and Biophysical Research Communications, 1998
- The HLA-G gene is expressed at a low mRNA level in different human cells and tissuesHuman Immunology, 1994
- Linkage Localization of TGFB2 and the Human Homeobox Gene HLX1 to Chromosome 1qGenomics, 1993
- Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistanceInternational Journal of Cancer, 1989
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.Journal of Experimental Medicine, 1987
- Lymphoid Cell-Glioma Cell Interaction Enhances Cell Coat Production by Human Gliomas: Novel Suppressor MechanismScience, 1983